Answers are grounded in this paper and cite their sources.
Case report highlights hemolytic anemia due to levetiracetam in an elderly patient, suggesting a serious reaction.
This is the case of a 77-year-old female patient with Alzheimer’s disease, complicated by partial complex seizures. Levetiracetam was administered, which provoked hemolytic anemia. An extensive laboratory evaluation was suggestive of a non-immune etiology. Subsequent discontinuation of levetiracetam resulted in improvement of hemoglobin. Pancytopenia has been reported with the use of levetiracetam, but not isolated anemia. With this case report, we want to increase awareness of a potentially serious adverse reaction provoked by levetiracetam, a preferred anticonvulsive drug in the geriatric population.
No takes yet. Share an insight, caveat, or question.
Cruz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: